4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Fate Therapeutics, Inc. (FATE) operates in the Biotechnology industry and is headquartered in San Diego, United States with about 161 employees. Its market capitalization is roughly $360 million. In the fiscal year ended 2025-12-31, FATE reported $7M in revenue and ($136M) in net income.
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally.
Interactive charts & full statements → Open the FATE valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $7M | $14M | $64M | $96M | — |
| Operating Income (EBIT) | ($148M) | ($196M) | ($190M) | ($308M) | — |
| Net Income | ($136M) | ($186M) | ($161M) | ($282M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $1M | $1M | $2M | $2M | $2M |
| Operating Income (EBIT) | ($33M) | ($35M) | ($35M) | ($37M) | ($41M) |
| Net Income | ($31M) | ($32M) | ($32M) | ($34M) | ($38M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $319M | $441M | $506M | $706M | — |
| Total Liabilities | $112M | $122M | $138M | $222M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive FATE viewer.
About TickerBase · Data methodology & sources